SCHEMBL109904

SCHEMBL109904

O=C1C(O)=CC(=O)c2c(O)cccc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.72
KDM4E B2RXH2 5/20 0.72
RECQL P46063 4/20 0.72
POLB P06746 2/20 0.72
ATM Q13315 1/20 0.72
KMT2A Q03164 5/20 0.68
ALDH1A1 P00352 4/20 0.68
HPGD P15428 4/20 0.68
MAPK1 P28482 4/20 0.68
MEN1 O00255 4/20 0.68
ALOX15 P16050 3/20 0.68
HSD17B10 Q99714 3/20 0.68
TDP1 Q9NUW8 3/20 0.68
CYP3A4 P08684 3/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
TRPA1 O75762 2/20 0.68
TP53 P04637 2/20 0.68
CASP1 P29466 2/20 0.68
CDC25B P30305 2/20 0.68
BLM P54132 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29405399 1.00 MAPT (0.72) MAPTKDM4ERECQLPOLBATM
SCHEMBL5175867 0.84 MAPT (0.72) MAPTKDM4ERECQLPOLBATM
SCHEMBL29728494 0.84 MAPT (0.72) MAPTKDM4ERECQLPOLBATM
SCHEMBL8663341 0.84 MAPT (1.00) MAPTKDM4ERECQLPOLBATM
SCHEMBL10391052 0.81 P4HB (0.74) MAPTKDM4ERECQLPOLBATM
Plumbagin SCHEMBL29386213 0.81 MAPT (1.00) MAPTKDM4ERECQLPOLBATM
SCHEMBL30003609 0.81 MAPT (0.64) MAPTKDM4ERECQLPOLBATM
SCHEMBL29647651 0.81 P4HB (0.74) MAPTKDM4ERECQLPOLBATM
SCHEMBL16879125 0.81 MAPT (0.64) MAPTKDM4ERECQLPOLBATM
Plumbagin SCHEMBL34186 0.81 MAPT (1.00) MAPTKDM4ERECQLPOLBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3280402-B1 TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING BIOMENDICS LLC (US) 2024-06-05 EP claimed
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative L'OREAL S.A. 2007-06-14 US claimed
US-20050183213-A1 Composition for dyeing keratin fibers, comprising at least one alcohol oxidase and at least one quinone direct dye, and process using this composition L'OREAL S.A. (FR) 2005-08-25 US claimed
EP-1559411-A1 Composition for dying keratinic fibers containing an alcohol oxidase and a quinonic dye, and the method for use of the composition L'OREAL (FR) 2005-08-03 EP claimed
EP-1434552-A1 METHOD FOR DYEING KERATINOUS FIBRES Henkel Kommanditgesellschaft auf Aktien (DE) 2004-07-07 EP claimed
US-6635090-B1 Dyeing method using a specific cationic derivative and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative L'OREAL, S.A. (FR) 2003-10-21 US claimed
WO-2003030841-A1 METHOD FOR DYEING KERATINOUS FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
US-6458168-B1 Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative L'OREAL S.A. (FR) 2002-10-01 US claimed
US-6451067-B1 HAIR DYE MIXTURE L'OREAL S.A. (FR) 2002-09-17 US claimed
US-5859066-A APPLYING AN EFFECTIVE AMOUNT A 1,4-NAPHTHOQUINONE TO THE AFFECTED AREA OF THE SKIN RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1999-01-12 US claimed
EP-0498707-B1 Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent OREAL (FR) 1995-08-02 EP claimed
EP-0565417-A1 Pigments consisting of an inorganic support and the reaction product of an indoline and a quinone derivative, their manufacturing process and their use in cosmetics L'OREAL (FR) 1993-10-13 EP claimed
EP-0498707-A1 Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent L'OREAL (FR) 1992-08-12 EP claimed
US-5064442-A HAIR DYES L'OREAL (FR) 1991-11-12 US claimed
US-4971596-A COPPER, COBALT, IRON OR SILVER SALTS WITH QUINONE DYES L'OREAL (FR) 1990-11-20 US claimed
US-4888026-A HAIR DYES; OXIDATION RESISTANCE L'OREAL (FR) 1989-12-19 US claimed
US-4832943-A HYDROXYQUINONE, MESOTARTARALDEHYDE L'OREAL (FR) 1989-05-23 US claimed
JP-58157705-A None JP disclosed
JP-S58157705-A AGRICULTURAL AND HORTICULTURAL GERMICIDE RIKAGAKU KENKYUSHO 1983-09-19 JP disclosed
EP-0047323-A1 1,4-NAPHTHOQUINONE DERIVATIVES AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative KRT18, NDUFB5, NDUFB7 MAPT 685/4885KDM4E 440/4885RECQL 1008/4885
US-20050183213-A1 Composition for dyeing keratin fibers, comprising at least one alcohol oxidase and at least one quinone direct dye, and process using this composition KRT18, ADH5, ADH1A MAPT 688/4885KDM4E 1088/4885RECQL 1220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.